TLR9 and systemic lupus erythematosus: As the processing of TLR9 and TLR7 into their active forms involves acid-requiring proteases in endosomes66, the efficacy of hydroxychloroquine in patients with systemic lupus erythematosus may result- from inhibition of TLR7 and TLR9 activity.